Key takeaways TRIUMPH-4 is the first successful Phase 3 readout for retatrutide, reporting 28.7% mean body-weight reduction at 68 weeks on the 12 mg weekly dose (26.4% on 9 mg, 2.1% on placebo)
Sterility testing to confirm compliance with research-grade standards
Dose modification represents a common management strategy
And second, a lot of the time what we're told is to lose weight, says Kerry Krauss, MD, an OB-GYN who has PCOS herself
Telehealth platforms like Doctronic.ai offer convenient, affordable access to licensed doctors across all 50 states
This means you have about a month to use the medication once you open the vial, but you must follow strict storage guidelines to maintain its effectiveness